Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,018,870
+$103,667 QoQ
Shares Held
94,207
+15.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#133
of 712 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest Bancshares, Inc. holds $21,127,120 across 8 Drug Manufacturers - General names. SNY ranks #2 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
53,406 | $6,862,671 | |
| 2 | SNY |
Sanofi
This page
|
94,207 | $4,018,870 | |
| 3 | LLY |
ELI LILLY & Co
|
2,573 | $3,086,133 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
19,719 | $2,491,297 | |
| 5 | JNJ |
Johnson & Johnson
|
9,353 | $2,375,381 | |
| 6 | ABBV |
AbbVie Inc.
|
5,470 | $1,376,469 | |
| 7 | PFE |
Pfizer Inc
|
24,413 | $587,865 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,700 | $328,434 |
All Filings in SNY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,018,870 | 94,207 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,915,203 | 81,262 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,776,681 | 77,934 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,149,635 | 87,916 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,938,472 | 81,525 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,431,087 | 79,897 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,180,334 | 65,941 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,430,030 | 24,814 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||